Patch-Type Wearable EEG Sleep Monitoring System

April 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2604E03] Slowave Inc. is a digital neuro-healthcare company that supports clinical decision-making through patch-type wearable electroencephalogram (EEG) sensor technology and advanced signal analysis algorithms.
Slowave has independently developed lightweight, wireless wearable EEG devices and precision signal processing technology, and continues to conduct research and development aimed at acquiring quantitative brain-signal data applicable to various neuropsychiatric conditions, including sleep disorders, delirium, and ADHD.

Slowave is further advancing its brain-signal analysis capabilities into clinically applicable diagnostic support systems. In the future, the company plans to integrate neuromodulation technologies to link analysis and treatment, expanding into precision neuro-medicine systems. Through this approach, Slowave aims to grow as a neurotech company contributing to the establishment of data-driven neurological disease-management environments.
Slowave has completed international CB certification and GMP certification for its proprietary patch-type wearable EEG hardware, securing medical device–level technical reliability and manufacturing quality-management standards. Based on this foundation, the company has commercialized its lightweight, wireless brainwave monitoring system, SLOWAVE 1.0 ― providing quantitative EEG data that clinicians can reference during patient consultations and expanding its potential for clinical application.

Slowave is also engaged in international research collaboration. Slowave is conducting joint research on EEG-based delirium analysis with the University of Michigan Medical School in the United States and is expanding its clinical research network in the U.S. market. In addition, the company plans to participate in the SLEEP 2026 conference and exhibition to be held in Baltimore, USA ― in order to validate its technology in North America and broaden global partnerships.
‘SLOWAVE 1.0’ is a Class II medical device certified by Korea’s Ministry of Food and Drug Safety (MFDS). It is a wireless, wearable EEG-based sleep monitoring system developed to complement the limitations of conventional hospital-based testing environments. By applying a patch-type electrode structure, it reduces the inconvenience of multi-channel electrode attachment and dependence on large diagnostic equipment. Once prescribed, patients can conduct sleep measurements at home or in other convenient environments, and clinicians review the analyzed results during consultations. This model enhances the traditional single-session, hospital-based testing structure by enabling repeated and continuous brainwave monitoring.

Notably, Slowave utilizes its proprietary Phase Information Analysis (PIA) algorithm to perform precise EEG signal analysis. The system aims to provide quantitative data applicable not only to sleep disorder evaluation but also to neuropsychiatric conditions such as delirium and ADHD.
Slowave has identified the United States and Japan as its primary target markets. The United States is experiencing rapid growth in digital health and neurotechnology sectors, with increasing demand for data-driven assessment of sleep disorders and neuropsychiatric conditions. Building on its research collaboration with the University of Michigan Medical School, Slowave plans to expand partnerships with major university hospitals and sleep medicine institutions for joint research and clinical applications.
Japan, a country facing rapid population aging, is also seeing increased demand for delirium and sleep disorder management. Slowave plans to secure clinical data through joint research with local university hospitals and research institutions and pursue market entry in collaboration with Japanese medical device companies.
As part of its U.S. expansion strategy, Slowave plans to participate in SLEEP 2026 and HLTH exhibitions to strengthen its network with sleep medicine researchers and clinicians, while exploring partnership opportunities with global digital health companies and investors. Through a phased global partnership strategy, the company aims to expand its presence in the digital neuro-healthcare sector.


korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Digital Medical & Health Support Devices

April 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2604E02] VIV Health is a startup developing wearable digital healthcare devices, offering personalized health-management solutions based on biosignal processing algorithms and AI-driven analytics.
The company has advanced its core technologies in collaboration with Professor Wonseok Jang (CSO) ― formerly of Samsung Medison and Siemens Medical R&D, and currently a professor in the Department of Medical Device Industry at Yonsei University College of Medicine.
VIV Health is continuing its research and development activities at the Seoul Biohub.
On February 5, 2026, the main functions of VIV Health’s smart ring, VIV™ Ring, were officially registered under the Ministry of Food and Drug Safety’s ‘Digital Medical & Health Support Device’ framework. This marks the first case in Korea of a wearable device ― specifically in smart ring form ― being registered under this system. The registration is significant in that the device’s intended purpose and functions have been formally recognized within the institutional regulatory framework established under Korea’s Digital Medical Products Act implemented last year.
Following Samsung Electronics’ prior registration of heart rate, blood oxygen saturation, and step-counting functions within the Samsung Health app, VIV Health completed registration for the smart ring hardware itself, thereby establishing a differentiated position in the hardware-based wearable market.

The VIV™ Ring is a titanium smart ring equipped with a high-precision PPG sensor and AI-based biosignal processing algorithms, designed for 24-hour continuous monitoring. It measures and analyzes key biosignals and activity data, including heart rate, blood oxygen saturation, and step count ― while also tracking sleep, stress, heart rate variability (HRV), and exercise data in an integrated manner. Through AI analysis, the device classifies user types and provides personalized health insights.
In addition, it includes a sleep-inducing sound feature aimed at improving the sleep environment, moving beyond simple measurement toward a preventive, lifestyle improvement-focused health management model. Users can automatically measure biosignals simply by wearing the device without manual operation, and receive alerts when abnormal signs are detected. Real-time measurement functions are also available when immediate status confirmation is needed.
VIV Health is targeting both B2C and B2B markets through a scalable revenue model that combines hardware with subscription-based (SaaS) services. In Korea, the company is pursuing collaborations with healthcare platform providers, major insurance companies, and construction firms. Overseas, it is expanding OEM agreements across the United States, the Middle East, Europe, Asia, and Latin America, pursuing a diversified global market strategy rather than focusing on a single country.
VIV Health’s last participation in KIMES 2026 served as a strategic entry point for expanding into the domestic market following MFDS registration. At the exhibition, VIV Health plans to directly introduce to medical professionals and industry stakeholders the upgraded UX/UI and the smart ring’s suitability and practical applications for measuring and analyzing biosignals to support medical care and maintain or enhance health.
VIV Health highlights the fact that many chronic conditions — such as obesity, dyslipidemia, diabetes, depression, and sleep disorders — are closely related to lifestyle habits. Given that daily management is critical, 24-hour monitoring through wearable devices can establish a new standard for preventive health management.
Through its smart ring, VIV Health aims to build a data-driven health management ecosystem and grow as a company that advances preventive, lifestyle-centered care models within the wearable digital healthcare sector.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: ,

Complete AI-Based Treatment Process for Musculoskeletal Diseases

April 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2604E01] CONNECTEVE Co., Ltd. is a medical artificial intelligence (AI) company that digitally connects the entire treatment process of musculoskeletal diseases — from diagnosis, to surgery, and post-operative management — based on AI technology.
By combining more than 100,000 high-quality proprietary medical data cases with deep learning technology, CONNECTEVE has introduced CONNEVO KOA, CONNEVO Metric, and CONNEVO Suite. Recently, the company obtained European CE MDR certification and conducted PoC projects in the Middle East, demonstrating its technological capabilities in the global market and continuing its growth trajectory.

CONNECTEVE is expanding its clinical references centered on major tertiary hospitals in Korea. To implement its solutions, the company collaborates with Seoul National University Hospital, Chung-Ang University Hospital, Wonju Medical Center, Uijeongbu St. Mary’s Hospital, and CHA Bundang Medical Center.
An increasing number of adoption and demo requests are being received from secondary-level medical institutions. Overseas, active PoC projects are underway at Burjeel Hospital in the UAE and Tzu Chi Hospital in Indonesia, while clinical collaborations are being prepared with hospitals in advanced medical markets such as the United States, Japan, Singapore, Germany, and Belgium. This global network serves as a foundation for CONNECTEVE’s AI solutions to establish themselves as internationally recognized clinical tools.
CONNECTEVE’s CONNEVO Metric automatically measures lower-limb alignment and angular data, enabling data-based comparison of pre- and post-surgical changes. CONNEVO Suite integrates these diagnostic data and provides an environment optimized for clinical workflow, improving hospital operational efficiency. A key strength is its ability to reduce variability that may arise from manual measurement processes, and enable explanations based on objective numerical values.

CONNECTEVE has designated the Middle East (UAE), Southeast Asia (Indonesia and Singapore), and Europe (Germany and Belgium) as its key target markets. In the Middle East and Southeast Asia, where medical infrastructure modernization is rapidly progressing, demand for AI solutions that improve clinical efficiency is increasing. In Europe, the company is pursuing full-scale market entry based on CE MDR certification. Building on collaboration cases with regional flagship hospitals, CONNECTEVE plans to expand partnerships with global hospital chains and distribution partners.
Moving forward, CONNECTEVE will continue participating in major medical exhibitions and academic conferences in North America, Europe, and Asia to strengthen its global network ― while implementing localization strategies tailored to each country’s medical environment. With the goal of achieving orthopedic digital transformation that connects diagnosis to surgery, the company plans to expand R&D investment and advance as a global medical AI company providing a data-driven treatment environment for both physicians and patients.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Korea’s Exports Continue Growth

April 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Recording trade surplus of $4.28 billion in March
Korea’s exports in March continued their growth trend for the sixth consecutive month despite a decrease in the number of working days, marking the tenth consecutive month of trade surplus. Semiconductor exports, the country’s largest export item, drove this growth by achieving their highest performance in 24 months.
According to the nation’s Ministry of Trade, Industry and Energy, exports in March totaled $56.56 billion, a 3.1% increase year-on-year, while imports recorded $52.28 billion, a 12.3% decrease over the same period. Consequently, the trade balance ― exports minus imports ― reached $4.28 billion, marking a streak of surpluses for the tenth consecutive month.
March exports were very positive, increasing compared to the previous year despite a 1.5 working days decrease (two-day on weekdays). Average daily exports, adjusted for working days, also recorded $2.51 billion ― a 9.9% increase from the previous year.
This trade surplus was the result of increased exports in seven of the 15 major export items. In particular, IT items (semiconductors, displays, computers, and wireless communication devices) led the nation’s exports by recording positive growth for the first time in 24 months since March 2022.

Exports of semiconductors, the largest export item, reached $11.7 billion in March ― marking the highest performance in 24 months since March 2022 ($13.1 billion) and continuing a positive trend for five consecutive months.
Exports of displays increased by 16.2% year-on-year, showing an upward trend for eight consecutive months, while computer SSDs rose by 24.5%, marking three consecutive months of growth.
Meanwhile, exports of ships surged by a massive 102.1%, continuing their positive trend for eight consecutive months. Exports of biohealth products also rose by 10.0%, marking five consecutive months of growth. In addition, exports of petroleum products also turned positive after just one month.

Movements toward Releasing Attractive New Items Continuing
Korean companies are continuously developing and launching new products. Striving to achieve their export performance goals for this year, steady efforts are being continued to strategically engage in research and development and market development.

Silla Systems’ flagship product, Pine-DX, is a multi-skeletal disorder diagnostic-support and integrated-analysis software solution. The system is designed to allow modular or integrated use, depending on the needs of medical institutions and screening centers.
Key functions include scoliosis analysis (Cobb’s angle and Nash-Moe analysis), bone-age assessment, ankle instability and knee ligament injury analysis, and flatfoot measurement.
VIV Health’s VIV™ Ring is a titanium smart ring equipped with a high-precision PPG sensor and AI-based biosignal-processing algorithms, designed for 24-hour continuous monitoring.
It measures and analyzes key biosignals and activity data, including heart rate, blood oxygen saturation, and step count ― while also tracking sleep, stress, heart-rate variability (HRV), and exercise data in an integrated manner. Through AI analysis, the device classifies user types and provides personalized health insights.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Cloud-based EMR/CRM Integrated Solutions

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E12] TNH Co., Ltd. is a healthcare IT company that has focused on addressing the structural challenges in healthcare. Since its founding in 2008, TNH has focused on developing specialized hospital software and has consistently provided solutions tailored to the hospital operating environment, focusing on cloud-based EMR and CRM.
TNH’s unique strength lies in expanding its solutions beyond simple electronic chart provision to encompass the entire hospital workflow, encompassing reservations, treatment, consultations, payments, insurance claims, and post-mortem care, all within a single system.

Its VegasCRM is a cloud-based EMR/CRM integrated solution for dermatology, aesthetics, and plastic surgery hospitals and clinics. It is designed to integrate not only medical record management but also reservations, customer management, and insurance claims into a single system.
Real-time status boards, treatment room status boards, and a smart reservation system allow for a comprehensive overview of hospital operations. It also offers customer management through point payment and deduction functions, and pick-up desk-based treatment distribution and statistics.

The reception and consultation function using tablet charts is also a factor that increases field usability.
TNH’s HanChart Cloud is a cloud-based electronic chart solution designed specifically for the environment of Oriental medicine clinics. It supports stable hospital operations without space or equipment constraints. It also features enhanced features specific to Korean Oriental medicine clinics, such as beauty treatment image storage, CRM functionality, kiosk (HIOSK) integration for registration, and certificate issuance.

Furthermore, TNH plans to gradually introduce a solution with enhanced field usability and mobile scalability via the tablet-based medical app Mediclo. Through these initiatives, TNH aims to more organically connect EMR and CRM-based hospital operating environments and continue its role as a technology partner that reduces actual workloads in the medical field.
Currently, TNH’s solutions are used in over 3,000 hospitals and clinics nationwide, with over 15,000 medical professionals and hospital staff utilizing them in real time on average daily. TNH continues its steady growth, with revenue of KRW 5 billion in 2022, KRW 6.2 billion in 2023, KRW 8.1 billion in 2024, and KRW 9.2 billion in 2025. This success is attributed to long-term customer retention and solution reliability.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Portable Cooling Device

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E13] ICE LINKER Co., Ltd., a spin-off company of Samsung C-LAB, recently introduced the world’s first portable cooling device, Ella Thera, which can cool the skin to -10°C.
Ella Thera is a portable, two-in-one device that cools to -10°C in under 100 seconds. The temperature and functionality can be freely adjusted to suit a variety of individual needs.
The company emphasizes that the skin cooler function cools the skin and relieves pain and swelling, while the warming function relaxes muscles and promotes blood circulation. The device’s unique dual function, combining cooling and heating, allows for massage and skin care anytime, anywhere.

ICE LINKER confirmed its necessity and excellence through such various events as the Tokyo Show in Japan, the Innotech Invention Competition in Taiwan, and KIMES in Korea. Ella Thera is scheduled to be marketed as a medical device starting in 2026.
ICE LINKER is currently jointly developing various products utilizing its rapid cooling technology with mid-sized and large companies, and plans to sequentially introduce a lineup of approximately 30 products to the market. Through this, the company aims to become a specialized cooling technology company that addresses heat-related discomfort.
ICE LINKER inherited Samsung Electronics’ innovative culture and was born from a recognition of its future potential. ICE LINKER is a leading company driving innovation in the global market through cutting-edge digital cooling technology. Based on its innovative solutions and technological prowess, the company delivers quality and service that exceeds customer expectations.

ICE LINKERis a company born from Samsung Electronics’ DNA of innovation, and is recognized for its future potential. It is a leading company driving innovation in the global market through cutting-edge digital cooling technology. Based on its innovative solutions and technological prowess, ICE LINKER delivers quality and service that exceeds its customers’ expectations.
ICE LINKER aims to address heat-related issues across various sectors, including people, objects, and society, utilizing its digital cooling technology. Currently, ICE LINKER has developed and mass-produced one medical product and two wellness products by using its rapid cooling technology.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Skin Diagnostic Devices

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E11] PSI Plus Co., Ltd. is an R&D-focused company that develops and manufactures skin diagnostic devices that quantitatively analyze skin conditions based on image-processing technology. Through technical collaboration with PSI Co., Ltd., which has accumulated expertise in the field of optical instruments, PSI Plus continues to introduce skin diagnostic solutions suitable for professional environments such as hospitals, dermatology, plastic surgery clinics, and cosmetic research laboratories.
PSI Plus’s skin diagnostic devices capture facial images using four different light sources and analyze a total of 14 skin parameters based on the acquired data. These devices are primarily used in medical institutions, skin clinical evaluation centers, and cosmetic development and marketing environments. Recently, the company has been advancing its technology toward providing personalized diagnostic solutions by accumulating and analyzing data on age-related skin changes.
In the domestic market, more than 2,500 skin diagnostic devices have been installed, demonstrating high utilization rates particularly in hospitals and dermatology clinics. This extensive real-world usage base enhances technological credibility, and has led to collaborations with numerous domestic cosmetic companies. Sales have shown steady growth, with the proportion of overseas revenue also gradually increasing.

Its current flagship product, 3D Meta-Vu, is a 3D skin analysis system equipped with full-spectrum LED light sources, enabling three-dimensional analysis of facial contours and skin conditions with a single capture.
By combining the strengths of existing 3D scanning equipment and facial-skin analyzers, this device is designed to simultaneously identify volume changes and skin problems while capturing images in a light-blocking environment. It enhances the reliability of before-and-after comparisons of subtle skin changes, making it ideal for consultations for various procedures, including laser, filler, and botox.

PSI Plus’s Mark-Vu is a premium professional skin analysis device that delivers uniform image quality across diverse environments through its LED light sources and polarized filter in-out system. Based on proprietary resolution algorithms and analysis logic, it precisely evaluates the state of pores, sebum, pigmentation, and blood vessels. The placement of the capture button on the top of the device enhances both ease of use and reproducibility.
PSI Plus’s Line-Vu is a model designed with space efficiency and accessibility in mind, making it suitable for use in skincare rooms and small clinics. While retaining core analysis functions, it provides an intuitive user environment, expanding its applicability beyond medical settings into aesthetic care fields.

PSI Plus has applied Dark Skin Analysis Logic capable of analyzing a wide range of skin tones, enabling effective use in markets with a high proportion of darker skin tones, such as the Middle East, Latin America, and Africa. In addition, PSI Plus is increasing understanding during the consultation stage through virtual laser treatment simulation, and wrinkle and pigmentation change prediction functions.
PSI Plus supplies its products to multiple countries including the United States, Japan, France, and India, and is expanding global partnerships through participation in major international exhibitions such as MEDICA, Arab Health, and Hospitalar. Looking ahead, the company plans to further strengthen localized solutions with a focus on Brazil, the Middle East, and Europe.
PSI Plus is expanding its skin analysis technology beyond diagnostic devices into data-driven medical and aesthetic solutions, continuously advancing product development that reflects diverse skin characteristics and market demands. Through these efforts, the company is gradually enhancing the global competitiveness of Korean technology in the skin diagnostics market.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Autonomous Mobile Robot

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E10] SAMICK THK Co., Ltd. exhibited the NX-mobile AMR, an autonomous mobile robot (AMR) that combines a multi-joint robot with a humanoid-shape at SEMICON KOREA 2026.
The product performs various tasks based on a multi-joint robot. Two cameras mounted on the robot head provide three-dimensional perception of the surrounding environment, while hand cameras at the end of each joint capture the shape of the workpiece. Based on this information, the AMR can perform autonomous operations, such as loading items into empty spaces in a storage bin or, conversely, checking the location and retrieving items.
The AMR features a lifting axis that moves the robot up and down, allowing it to flexibly adjust its position to the height of the workpiece. It is also equipped with various sensors and scanners for safety. Furthermore, the built-in pneumatic device generates the compressed air required for robot operation without the need for separate equipment.
A spokesperson for the company explained, “It can be used in environments requiring organization or frequent material transport,” adding, “We are continuing to develop various robot and automation solutions with the goal of becoming a company that provides full-cycle smart factory solutions.”

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

High-power Laser Equipment

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E09] Founded in 1988, Union Medical Co., Ltd. is a medical device manufacturer specializing in the development and manufacture of various laser and energy-based medical devices, including electrosurgical devices and CO₂ lasers, using proprietary technology.
Union Medical continues to expand its global market by building a differentiated technology portfolio that includes 1450nm, 1550nm, and 1927nm lasers, multi-pulse IPL, pneumatic injection systems utilizing air, and high-frequency hyperthermia cancer-treatment devices.
To strengthen its quality competitiveness and to meet global standards, Union Medical has obtained ISO, GMP, and MDSAP certifications. Based on individual country-specific approvals, it is actively expanding into overseas markets.
In Korea, Union Medical has maintained steady sales based on its long-standing brand recognition and stable distribution network. In overseas markets, the company achieved record sales in 2025, demonstrating the success of its sales-channel diversification. In the Japanese market, in particular, the company has maintained stable performance, supplying over 100 CO₂ laser devices annually for over 20 years.
Union Medical recently showcased its key product lineup targeting the aesthetics and skincare markets, focusing on high-power laser equipment. Last year, it showcased the technological prowess of its existing products to both domestic medical professionals and international buyers.

Diode Laser Device
Union Medical’s flagship product, the NEOBEAM, is a 1450nm diode laser device characterized by its high absorption by water and sebum. With a high-output of 25W, it delivers consistent energy even through a 10mm lens, enabling deep energy penetration and shortening treatment times. Furthermore, the device features a cooling system to reduce the risk of burns and is designed with the safety of both users and patients in mind.

Dual Fractional Laser Device
Union Medical’s DE ORO DUAL is a dual fractional laser device that integrates two-wavelength lasers ― 1550nm and 1927nm ― into a single system. Designed to simultaneously target both epidermal and dermal lesions, its high output and small beam size maximize treatment effectiveness while minimizing side effects. Its flexibility in adapting to a variety of skin types and treatment objectives makes it a highly useful clinical device.
Union Medical is expanding its overseas business, targeting Japan and Brazil as key target markets. In Japan, the company is expanding its product line with a variety of laser devices, leveraging its experience in selling CO₂ lasers. It also plans to strengthen its presence among medical professionals through participation in relevant academic conferences. In Brazil, considering the high demand for skincare products, the company is establishing a bridgehead for full-scale market entry based on its MDSAP certification.
Going forward, Union Medical plans to respond to the rapidly evolving demands of the aesthetic medicine market through continued investment in R&D, and to expand its reach to global buyers by participating in key international academic conferences and exhibitions, such as IMCAS, DUBAI DERMA, and AMWC. In 2026, it plans to introduce differentiated new products that reflect customer needs and further strengthen its competitiveness in the laser-based aesthetic medical device market. 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Medical Devices

March 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2603E08] Founded in 2005, WON MEDCO leverages its 25 years of accumulated laser manufacturing expertise to develop innovative medical and homecare devices, elevating the status of K-beauty in the global market. With its superior technology and extensive clinical data, the company provides customers with trustworthy products and sets new standards for skin care and beauty.
Through its flagship brand, CLABIANE, the company offers a diverse range of products that combine expertise and quality, and through continuous research and innovation, it is leading the way in creating a new culture of skin care.

Homecare Complex Beauty Device
WON MEDCO’s Oligihome is an innovative homecare complex beauty device that combines five functions ― HIFU, RF, AP, LDM, and LED ― in a single device. By integrating various technologies, this device offers the convenience of receiving all your beauty care needs in one place, thus eliminating the need for multiple individual devices.
Combining technologies such as RF (Radio Frequency), EP (Electroporation), LDM (Local Dynamic Micro-massage, or water drop lift ultrasound), and LED light therapy, the device offers a variety of benefits, including skin elasticity enhancement, wrinkle improvement, lifting, tightening, and skin soothing.
These features effectively address the diverse skin concerns of various skin types and promote overall improvement. Instead of complex buttons, the device features an intuitive touchscreen for maximum user convenience.
Simple operation allows users to easily select their desired functions, making it simple for anyone to use. Boasting a sophisticated design and outstanding performance, this device allows users to experience professional-level beauty care at home.

Hair-loss Treatment Medical Device
WON MEDCO’s Hair Beam Air is the first hair-loss treatment medical device developed in Korea, in 2009. Approved by the Ministry of Food and Drug Safety, it utilizes LLLT (low-level laser therapy) technology.
When blood flow and oxygen levels in the blood vessels connected to the hair follicles increase by directly delivering LD and LED light to the scalp, it increases blood flow and oxygen levels in the blood vessels connected to the hair follicles. This stimulates capillaries, dilating and supplying nutrients to the hair follicles and roots, thereby promoting hair growth and enhancing hair thickness. It is effective in treating hair loss, strengthening hair thickness, increasing hair density, accelerating hair growth, regenerating aged hair, repairing damaged hair, and providing scalp care.

WON MEDCO is the first in Korea to complete clinical trials at two national university hospitals (Seoul National University Bundang Hospital, and Kyungpook National University Hospital) for its latest Hair Beam Air for hair-loss treatment.
The clinical results showed that after six months of use, the number of hairs per 1cm² increased by 17.2, and hair thickness increased by an average of 12.6 μm. These are the best and most reliable figures for hair-loss treatments in Korea. In addition, its Hair Beam Air holds numerous patents and awards as the world’s first helmet-type hair-loss treatment device.
“Founded in 2005, WON MEDCO is a subsidiary of Wontech, a laser medical device manufacturer. We manufacture and sell medical devices for dermatology and aesthetics, homecare beauty devices, and medical skincare products. Developed in collaboration with leading experts, we offer high-quality products that will help you restore your skin’s natural beauty,” remarked the company’s CEO.

korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:
«Previous Page
Next Page»